Jackson Financial Inc. (0JKF)
London Exchange · UK · prices in USD · close of 22 Oct 2026
Key indicators
| Last close | USD 131.70 |
|---|---|
| 52-week range | 20.18 – 157.82 |
| Return, 1 month / 3 months | +0.4% / +7.4% |
| Return, 1 year / 3 years | +38.0% / +619.4% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 51 |
| Volatility (1 year) | 259.5% |
| Worst drawdown (1 year) | -83.8% |
| Average daily value traded | 0.06M USD |
| Dividend yield | 2.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Jackson Financial is the parent company of Jackson National Life Insurance, a United States life insurer based in Lansing, Michigan. It focuses on retirement savings products, chiefly annuities such as fixed, variable and registered index-linked annuities, sold to individual savers and their advisers. The company also offers life insurance and related services, and it distributes its products through independent advisers, banks and other intermediaries across the American market.
The shares are listed on the London Exchange in UK under the code 0JKF, and the price on this page is in US dollars (USD). Our dividend records, which start in 2019, show payments in 4 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Jackson Financial Inc. (0JKF) trades on the London Exchange in UK. It last closed at USD 131.70 on 22 October 2026.
Its price-based Market X-Ray is 48 out of 100 (a weak price profile), ranking 2,195 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 38.0% and over the last three months it rose 7.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 83 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 13.9% | ||
| From 52-week high | -6.3% | ||
| Momentum | 79 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 7.4% | ||
| 6-month return | 19.8% | ||
| 12-month return, skipping the last month | 37.4% | ||
| Stability (higher is calmer) | 2 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 259.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -83.8% | ||
| Liquidity | 26 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.06M USD | ||
| Zero-volume days | 0.0% | ||
| Income | 28 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.7% | ||
| Years with dividends | 4 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | +1.2% |
|---|---|
| 1 month | +0.4% |
| 3 months | +7.4% |
| 6 months | +19.8% |
| 1 year | +38.0% |
| 3 years | +619.4% |
| 5 years | +477.3% |
Signals
| 50-day / 200-day average | 132.67 / 115.65 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 3.98 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 15 Sep 2026 | USD 0.9000 |
| 11 Jun 2026 | USD 0.9000 |
| 16 Mar 2026 | USD 0.9000 |
| 4 Dec 2025 | USD 0.8000 |
| 15 Sep 2025 | USD 0.8000 |
| 12 Jun 2025 | USD 0.8000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.